Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
ASCEPT was founded in 1966, and held its first scientific meeting a year later. Since that time, ASCEPT has developed into the peak professional society devoted to advancing excellence in Clinical and Experimental Pharmacology and Toxicology in Australasia.
THINKING OF JOINING?
We promote advances in research, provide teaching & training and ensure that ASCEPT has a major role in advising government and other organisations on related matters. You can also benefit from discounted rates and networking opportunities.
SCIENTIFIC MEETINGS
ASCEPT 2021 Virtual Annual Scientific Meeting
29 November – 2 December 2021
SPECIAL INTEREST GROUPS
ASCEPT members have many diverse interests and so have formed Special Interest Groups to acknowledge these strengths, to enhance the cohesion of the Society and to promote and advance the study and application of pharmacology and toxicology in its broadest context.
ASCEPT recent articles and events
Latest News
Twitter Feed
PhD Opportunities
Are you looking for an exciting PhD opportunity with industry focus? Join the ARC Industrial Transformation Training Centre for Cryo-electron Microscopy of Membrane Proteins (CCeMMP)!
Twitter Feed
Have you submitted your abstract for #ASCEPT2021!? Submission deadline is three days away - Monday 13th of September at 5pm! 😮 Submit your abstract NOW at 👉👉https://www.asceptasm.com/2021-annual-scientific-meeting-2/abstract-submission-2021/
@ASCEPTanz @wrida959
You may know we've been working on a veterinary prescribing assessment (VetPAT) with the @UniOfSurrey. The results from the pilot have been presented at #Pharmacology21 as an iposter. Join the authors to discuss the pilot and the findings!
2
Substantial positive feedback from @BritPharmSoc community post #Pharmacology2021 talk - E/Pres J.Aronson alerts to his @bmj_latest over the pandemic which we should revisit - https://go.shr.lc/3lnItSj
"On pharmacokinetic grounds alone, ivermectin is unlikely to be beneficial"
Special Interest Groups
Supporting Member Collaboration
ASCEPT members have many diverse interests and so have formed Special Interest Groups to acknowledge these strengths, to enhance the cohesion of the Society and to promote and advance the study and application of pharmacology and toxicology in its broadest context. Currently, there are SIGs in the following areas.
Clinical Pharmacology
Clinical Pharmacology involves all aspects of safe, effective and rational use of medicines in humans (individual, group, or population levels).
Click here
Cardiovascular
The Cardiovascular SIG (formed in 2008) aims to foster collaboration and exchange of ideas across all areas of cardiovascular research.
Click here
Drug Disposition and Response
Drug Disposition and Response involves the distribution, metabolism and excretion of drug and the relationship between drug concentrations and effects..
Click here
Education Forum
A conduit for the sharing of ideas and resources between those involved in pharmacology education, with the overall aim of ensuring that all students of pharmacology receive a quality education that prepares them for their future careers.
Click here
Pharmacogenomics
The Pharmacogenomics SIG addresses molecular mechanisms, clinical impact and public health implications of genomics affecting drug response and adverse effects.
Click here
Student Forum
The Student Forum is currently under construction and will be available in the near future.
Click here
New Zealand Forum
To provide an annual forum to promote and disseminate pharmacology & toxicology research, clinical practice and education within New Zealand and beyond.
Click here
Toxicology
Open to all who have an interest in toxicology. Including but not limited to drugs, medicines and consumer product toxicity, pesticides and agrichemicals, nanomaterials, occupational chemicals and industrial pollutants, naturally occurring toxic chemicals and poisons, poisoning management and clinical toxicity.
Click here
Urogenital and Gastrointestinal
The Urogenital/Gastrointestinal SIG promotes research in the field of urogenital and gastrointestinal pharmacology and disseminate findings to Australian researchers while encouraging early career researchers with opportunities to present their work.
Click here
Neuropharmacology
The Neuropharmacology and behavioural SIG is interested in how drugs affect cellular activity within the nervous system and how this influences behaviour.
Click here
Pharmacoepidemiology
The role of the Pharmacoepidemiology SIG is to promote and support pharmacoepidemiological research and collaboration within ASCEPT members.
Click here
Respiratory and Inflammation
The Respiratory & Inflammation SIG aims to facilitate cutting edge research in the areas of respiratory and inflammatory diseases.
Click here
Partners and Sponsors
